Sex differences in mortality in stable patients undergoing vasodilator stress cardiovascular magnetic resonance

Objective We assessed the influence of the ischaemic burden (IB) as derived from vasodilator stress cardiovascular magnetic resonance (CMR) on the risk of death and the effect of revascularisation across sex. Methods We evaluated 6237 consecutive patients with known or suspected chronic coronary syndrome (CCS). Extensive ischaemia was defined as >5 segments with perfusion deficit. Multivariate Cox proportional hazard regression models were used. Results A total of 2371 (38.0%) patients were women and 583 (9.3%) underwent CMR-related revascularisation. During a median follow-up of 5.13 years, 687 (11.0%) deaths were reported. We found an adjusted differential effect of CMR-derived IB across sex (p value for interaction=0.039). Women exhibited an adjusted lower risk of death and only equaled men’s risk when extensive ischaemia was present. Likewise, CMR-related revascularisation was shown to be differentially associated with the risk of mortality across sex (p value for interaction=0.025). In patients with non-extensive ischaemia, revascularisation was associated with a higher risk of death, with a greater extent in women. At higher IB, revascularisation was associated with a lower risk in men, with more uncertain results in women. Conclusions CMR-derived IB allows predicting the risk of death and gives insight into the potential effect of revascularisation in men and women with CCS. Compared with men, women with non-extensive ischaemia displayed a lower risk and a similar risk with a higher IB. The impact of CMR-related revascularisation on mortality risk was also significantly different according to IB and sex. Further research will be needed to confirm these hypothesis-generating findings.

[1]  V. Fuster,et al.  Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review. , 2020, Journal of the American College of Cardiology.

[2]  M. Woodward,et al.  Sex Differences in Incident and Recurrent Coronary Events and All-Cause Mortality. , 2020, Journal of the American College of Cardiology.

[3]  J. Núñez,et al.  Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease: A Large Retrospective Registry. , 2020, JACC. Cardiovascular imaging.

[4]  G. Stone,et al.  Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease , 2020, Circulation.

[5]  Sean M. O'Brien,et al.  Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial. , 2020, JAMA cardiology.

[6]  E. Antman,et al.  Managing Stable Ischemic Heart Disease. , 2020, The New England journal of medicine.

[7]  Sean M. O'Brien,et al.  Initial Invasive or Conservative Strategy for Stable Coronary Disease. , 2020, The New England journal of medicine.

[8]  S. Schulman,et al.  Stable ischemic heart disease: how to keep it that way. , 2020, The Journal of clinical investigation.

[9]  Christopher J. Rush,et al.  Ischemia and No Obstructive Coronary Artery Disease , 2019, Circulation. Cardiovascular interventions.

[10]  Susan Cheng,et al.  Coronary Microvascular Dysfunction Causing Cardiac Ischemia in Women. , 2019, JAMA.

[11]  L. Cho,et al.  Unique cardiovascular risk factors in women , 2019, Heart.

[12]  D. Mark,et al.  Revascularization in stable coronary disease: evidence and uncertainties , 2018, Nature Reviews Cardiology.

[13]  M. Eghbali,et al.  The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy , 2017, Biology of Sex Differences.

[14]  V. Lorenzoni,et al.  Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization. , 2017, JACC. Cardiovascular imaging.

[15]  J. Ge,et al.  Sex-based influence on clinical outcomes after drug-eluting stent implantation in real-world patients: insight from the FOCUS registry , 2017, Annals of medicine.

[16]  P. Libby,et al.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.

[17]  M. Karck,et al.  Female Gender and Differences in Outcome after Isolated Coronary Artery Bypass Graft Surgery: Does Age Play a Role? , 2016, PloS one.

[18]  Puja K. Mehta,et al.  Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy , 2015, Nature Reviews Cardiology.

[19]  A. Jacobs,et al.  Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes). , 2013, Journal of the American College of Cardiology.

[20]  E. Jones,et al.  Cardiac syndrome X and microvascular coronary dysfunction. , 2012, Trends in cardiovascular medicine.

[21]  R. Blankstein,et al.  Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. , 2011, JACC. Cardiovascular imaging.

[22]  M. Sabatine,et al.  Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. , 2008, JAMA.

[23]  J. Núñez,et al.  Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. , 2007, Journal of the American College of Cardiology.

[24]  S. Reis,et al.  Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. , 2006, Journal of the American College of Cardiology.

[25]  Jeroen J. Bax,et al.  Magnetic resonance imaging of coronary arteries, the ischemic cascade, and myocardial infarction. , 2005, American heart journal.

[26]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[27]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[28]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[29]  J. Núñez,et al.  Prognostic implications of dipyridamole cardiac MR imaging: a prospective multicenter registry. , 2012, Radiology.